Related Experiment Video

Updated: Oct 25, 2025

Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy
10:10

Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy

Published on: July 20, 2022

4.2K

A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in

Maxime Nachit1,2, Nicolas Lanthier1,3, Julie Rodriguez4

  • 1Laboratory of Hepato-Gastroenterology, Institut de Recherche Expérimentale et Clinique, UCLouvain, Université catholique de Louvain, Brussels, Belgium.

JHEP Reports : Innovation in Hepatology
|August 6, 2021
PubMed
Abstract

Keywords:
ALM, appendicular lean massALT, alanine aminotransferaseAST, aspartate aminotransferaseBIA, bioelectrical impedance analysisBMI, body mass indexCAP, controlled attenuation parameterCT scanCT, computed tomographyCTDIvol, volume CT dose indexDEXA, dual-energy X-ray absorptiometryDLP, dose–length productFFM, fat-free massHT, hypertensionHU, Hounsfield unitHbA1c, haemoglobin A1cITF, inulin-type fructansL3, third lumbar levelLiverM0, baselineM3, end of the 3-month interventionMAFL, metabolic associated fatty liverMAFLD, metabolic dysfunction-associated fatty liver diseaseMRI, magnetic resonance imagingMuscle fatMyosteatosisNASH, non-alcoholic steatohepatitisPMI, psoas muscle indexSMD, skeletal muscle densitySMDpsoas, psoas muscle densitySMFI, skeletal muscle fat indexSMFIpsoas, psoas fat indexSMI, skeletal muscle indexSMIbw, SMI scaled on body weightSMIht2, SMI scaled on height squaredSarcopeniaTE, transient elastographyγGT, γ-glutamyl transferase

More Related Videos

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.2K
Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH07:13

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH

Published on: April 20, 2021

4.2K

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
248
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
33
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
32
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
43
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
782
Liver Physiology01:30

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
2.1K